US adults eat a meal’s worth of calories of snacks in a day
Snacks constitute almost a quarter of a day’s calories in U.S. adults and account for about one-third of daily added sugar, a new study suggests. Researchers analyzing data from surveys of over 20,000 people found that Americans averaged about 400 to 500 calories in snacks a day – often more than what they consumed at […]
Free Online Learning for Older Adults Promotes Overall Wellness – Wyoming Department of Health
Free Online Learning for Older Adults Promotes Overall Wellness December 13, 2023 As the Wyoming Department of Health continues to a partner with the largest online learning platform designed specifically for older adults, a wide range of free classes remains available to older Wyoming adults. Jeff Clark, Community Health Section manager with the WDH Aging […]
This Many U.S. Adults Have Chronic Fatigue Syndrome
During 2021-2022, 1.3% of adults had myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), new National Health Interview Survey (NHIS) data showed. Women (1.7%) were more likely than men (0.9%) to have ME/CFS, according to Anjel Vahratian, PhD, MPH, of the CDC’s National Center for Health Statistics (NCHS), and co-authors. The percentage of people with ME/CFS rose with […]
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes
More than one in three adults have prediabetes, representing around 98 million Americans, but 81% of them don’t know it, the CDC said as part of a national PSA to raise awareness. The federal government’s dietary guidelines may soon warn against ultra-processed foods. (Washington Post) Two phase II trials found the investigative oral drug LUM-201 […]
Consequences of Oral Anticoagulant Choice Magnified in the Frail
Older adults with atrial fibrillation (Afib, or AF), especially those with frailty, had better patient-centered outcomes taking apixaban (Eliquis) than other common oral anticoagulants (OACs), Medicare records showed. Compared with apixaban, rivaroxaban (Xarelto) was associated with significantly increased risk of spending more than 14 days in the hospital or a skilled nursing facility during follow-up […]
Tirzepatide Wins FDA Approval for Weight Loss
The FDA approved tirzepatide (Zepbound), the latest injectable for chronic weight management in adults, the agency announced on Wednesday. The combination glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist is indicated for adults with obesity or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. Eli Lilly’s […]
Adults with ADHD are at increased risk for developing dementia
Adults with attention-deficit/hyperactivity disorder (ADHD) are nearly three times more likely to develop dementia than adults without ADHD, according to a Rutgers study. The study, coauthored by Michal Schnaider Beeri, director of the Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center at Rutgers Brain Health Institute (BHI) was published in JAMA Network Open. It followed […]
ADHD and Car Crashes; New Guidance on Stimulant Use Disorder Tx; KarXT Heads to FDA
Older adults with attention deficit-hyperactivity disorder (ADHD) had a significantly higher incidence of car crashes. (JAMA Network Open) Meanwhile, the estimated prevalence of ADHD in kids 4 years and up held steady — between 10.08% to 10.47% — from 2017 to 2022, according to nationally representative data. (JAMA Network Open) The FDA released new draft […]
Long COVID Rare in U.S. Kids, Has Affected 7% of Adults
Long COVID in the U.S. is rare among children and has affected roughly one in 14 adults, according to a pair of data briefs from the CDC’s National Center for Health Statistics (NCHS). Overall, in 2022, an estimated 1.3% of children in the U.S. ever had long COVID, and 0.5% currently had long COVID, reported […]
Inhaled Glucocorticoid Flops for Speeding COVID Recovery in Outpatients
Inhaled fluticasone furoate failed to shorten recovery time for non-hospitalized adults with COVID-19, new data from the adaptive ACTIV-6 trial found. When used daily for 2 weeks, a quicker COVID-19 recovery time — considered at least 3 consecutive days without symptoms — was no more likely with fluticasone furoate than with placebo (HR 1.01, 95% […]